DMS Imaging SA

XBRU:ALIMG (Belgium)  
€ 0.02 (-1.92%) Apr 23
At Loss
P/B:
2.91
Market Cap:
€ 30.39M ($ 32.52M)
Enterprise V:
€ 43.15M ($ 46.17M)
Volume:
22.58K
Avg Vol (2M):
55.09K
Also Trade In:
Volume:
22.58K
At Loss

Business Description

Description
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.29
Equity-to-Asset 0.23
Debt-to-Equity 1.81
Debt-to-EBITDA 8.86
Interest Coverage 0.03
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.75
Distress
Grey
Safe
Beneish M-Score -2.15
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate 72.7
3-Year FCF Growth Rate 63.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 50.46
9-Day RSI 51.26
14-Day RSI 51.05
6-1 Month Momentum % 35.71
12-1 Month Momentum % -15.56

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.62
Quick Ratio 0.87
Cash Ratio 0.27
Days Inventory 186.27
Days Sales Outstanding 55.98
Days Payable 96.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -308.2
Shareholder Yield % -11.17

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 33.31
Operating Margin % 0.04
Net Margin % -1.75
FCF Margin % -11.94
ROE % -6.67
ROA % -1.69
ROIC % 0.05
ROC (Joel Greenblatt) % -1.69
ROCE % -1.2

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.76
PB Ratio 2.91
EV-to-EBIT -155.22
EV-to-EBITDA 21.34
EV-to-Revenue 1.06
EV-to-FCF -8.91
Earnings Yield (Greenblatt) % -0.64
FCF Yield % -15.94

Financials

XBRU:ALIMG's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

DMS Imaging SA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 40.564
EPS (TTM) (€) -0.001
Beta 0.64
Volatility % 44.49
14-Day RSI 51.05
14-Day ATR (€) 0.002679
20-Day SMA (€) 0.019965
12-1 Month Momentum % -15.56
52-Week Range (€) 0.002 - 0.026
Shares Outstanding (Mil) 1,489.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

DMS Imaging SA Filings

Filing Date Document Date Form
No Filing Data

DMS Imaging SA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

DMS Imaging SA Frequently Asked Questions

What is DMS Imaging SA(XBRU:ALIMG)'s stock price today?
The current price of XBRU:ALIMG is €0.02. The 52 week high of XBRU:ALIMG is €0.03 and 52 week low is €0.00.
When is next earnings date of DMS Imaging SA(XBRU:ALIMG)?
The next earnings date of DMS Imaging SA(XBRU:ALIMG) is .
Does DMS Imaging SA(XBRU:ALIMG) pay dividends? If so, how much?
DMS Imaging SA(XBRU:ALIMG) does not pay dividend.

Press Release

Subject Date
No Press Release